Richard A. Miller MD - 07 May 2025 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Reporting relationship: President and CEO, Director
Issuer ticker: CRVS
Reported as of: 07 May 2025
Net transaction value: +$1,956,756
SEC form: 4
Accepted by SEC: 09 May 2025, 16:09:21 UTC
Prior SEC filing: 23 Dec 2024
Next SEC filing: 08 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Leiv Lea, as Attorney-in-Fact for Richard A. Miller

Key filing fact

Richard A. Miller MD filed Form 4 for Corvus Pharmaceuticals, Inc. (CRVS) on 09 May 2025.

Key facts

This page summarizes Richard A. Miller MD's Form 4 filing for Corvus Pharmaceuticals, Inc. (CRVS).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 09 May 2025, 16:09.

Change

Previous filing in this sequence was filed on 23 Dec 2024.
Current net transaction value: +$1,956,756.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001031847 Primary reporting owner

MILLER RICHARD A MD

Relationship: President and CEO, Director
Address: C/O CORVUS PHARMACEUTICALS, INC., 901 GATEWAY BOULEVARD, THIRD FLOOR, SOUTH SAN FRANCISCO
Signature: /s/ Leiv Lea, as Attorney-in-Fact for Richard A. Miller
Signature date: 09 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRVS transaction

Common Stock

Options Exercise

Transaction value: $1,956,756
Shares: +559,073
Change %: +97%
Price: $3.50
Shares after: 1,136,707
Date: 07 May 2025
Ownership: Direct

CRVS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,188,103
Date: 07 May 2025
Ownership: By Trust
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRVS transaction Derivative

Warrant (Right to Buy)

Options Exercise

Transaction value
Shares: -559,073
Change %: -100%
Price
Shares after: 0
Date: 07 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 559,073
Exercise price: $3.50
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.

Footnote F2

Issued at no additional consideration to the Reporting Person in connection with their subscription for shares of the Issuer's Common Stock at a price of $1.7312.